Danieli Andrade

3.4k total citations
66 papers, 1.3k citations indexed

About

Danieli Andrade is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Danieli Andrade has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Rheumatology, 21 papers in Hematology and 11 papers in Surgery. Recurrent topics in Danieli Andrade's work include Systemic Lupus Erythematosus Research (47 papers), Platelet Disorders and Treatments (19 papers) and Renal Diseases and Glomerulopathies (8 papers). Danieli Andrade is often cited by papers focused on Systemic Lupus Erythematosus Research (47 papers), Platelet Disorders and Treatments (19 papers) and Renal Diseases and Glomerulopathies (8 papers). Danieli Andrade collaborates with scholars based in Brazil, United States and Italy. Danieli Andrade's co-authors include Jane E. Salmon, Maria G. Tektonidou, Iuliana Shapira, Steven L. Allen, Doruk Erkan, Michelle Lopes, Rohan Willis, Hannah Cohen, Anisur Rahman and Thomas L. Ortel and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Danieli Andrade

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danieli Andrade Brazil 18 889 434 345 195 172 66 1.3k
Mary‐Carmen Amigo Mexico 23 1.3k 1.5× 605 1.4× 308 0.9× 327 1.7× 204 1.2× 50 1.6k
Nathalie Morel France 17 740 0.8× 234 0.5× 233 0.7× 166 0.9× 80 0.5× 44 997
Alberto Spindler Argentina 18 1.2k 1.4× 351 0.8× 600 1.7× 100 0.5× 101 0.6× 41 1.7k
Javier Cabiedes Mexico 25 1.8k 2.0× 712 1.6× 527 1.5× 202 1.0× 179 1.0× 60 2.3k
R. H. W. M. Derksen Netherlands 25 1.3k 1.5× 544 1.3× 619 1.8× 239 1.2× 139 0.8× 41 1.9k
F Mujić United Kingdom 7 965 1.1× 566 1.3× 141 0.4× 162 0.8× 258 1.5× 9 1.2k
Sonja Praprotnik Slovenia 24 732 0.8× 310 0.7× 463 1.3× 87 0.4× 304 1.8× 55 1.4k
Nicolas Limal France 20 376 0.4× 670 1.5× 283 0.8× 164 0.8× 181 1.1× 47 1.5k
Chi Hung To China 24 1.5k 1.7× 184 0.4× 747 2.2× 330 1.7× 91 0.5× 45 2.0k
M. Ruivard France 23 335 0.4× 606 1.4× 323 0.9× 105 0.5× 191 1.1× 98 1.6k

Countries citing papers authored by Danieli Andrade

Since Specialization
Citations

This map shows the geographic impact of Danieli Andrade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danieli Andrade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danieli Andrade more than expected).

Fields of papers citing papers by Danieli Andrade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danieli Andrade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danieli Andrade. The network helps show where Danieli Andrade may publish in the future.

Co-authorship network of co-authors of Danieli Andrade

This figure shows the co-authorship network connecting the top 25 collaborators of Danieli Andrade. A scholar is included among the top collaborators of Danieli Andrade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danieli Andrade. Danieli Andrade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chighizola, Cecilia Beatrice, Rohan Willis, Gabriella Maioli, et al.. (2024). Deciphering the clinical significance of longitudinal antiphospholipid antibody titers. Autoimmunity Reviews. 23(3). 103510–103510. 8 indexed citations
2.
Almeida, Matheus Oliveira de, et al.. (2023). Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis. JAMA Network Open. 6(5). e2315872–e2315872. 17 indexed citations
3.
Chighizola, Cecilia Beatrice, Francesca Pregnolato, Danieli Andrade, et al.. (2023). Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. Arthritis & Rheumatology. 75(6). 984–995. 12 indexed citations
4.
Andrade, Danieli & Maria G. Tektonidou. (2023). Assessing disease activity and damage in antiphospholipid syndrome. Clinical Immunology. 255. 109727–109727. 5 indexed citations
5.
Signorelli, Flávio, et al.. (2023). Ocular retinal findings in asymptomatic patients with antiphospholipid syndrome secondary to systemic lupus erythematosus. Clinical Rheumatology. 42(8). 2105–2114. 3 indexed citations
6.
Longobardi, Igor, Karla Fabiana Goessler, Gersiel Nascimento de Oliveira Júnior, et al.. (2023). Effects of a 16-week home-based exercise training programme on health-related quality of life, functional capacity, and persistent symptoms in survivors of severe/critical COVID-19: a randomised controlled trial. British Journal of Sports Medicine. 57(20). 1295–1303. 26 indexed citations
7.
8.
Erkan, Doruk, Savino Sciascia, María Laura Bertolaccini, et al.. (2021). Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current Rheumatology Reports. 23(7). 48–48. 1 indexed citations
9.
Erkan, Doruk, Savino Sciascia, María Laura Bertolaccini, et al.. (2021). Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current Rheumatology Reports. 23(6). 8 indexed citations
10.
Sciascia, Savino, Danieli Andrade, Tatsuya Atsumi, et al.. (2021). The role of antirheumatics in patients with COVID-19. The Lancet Rheumatology. 3(6). e447–e459. 35 indexed citations
11.
Velosa, Ana Paula Pereira, Solange Carrasco, Cecília Farhat, et al.. (2021). Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis. Frontiers in Immunology. 11. 604602–604602. 7 indexed citations
12.
13.
Cohen, Hannah, María J. Cuadrado, Doruk Erkan, et al.. (2020). 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus. 29(12). 1571–1593. 85 indexed citations
14.
Sobrado, Carlos Walter, et al.. (2020). Anorectal diseases in patients with Antiphospholipid syndrome: a cross-sectional study. Advances in Rheumatology. 60(1). 51–51.
15.
Lopes, Michelle, Elenice Mantovani, Virgínia Lúcia Nazário Bonoldi, et al.. (2019). Anti-collagen type v: a marker of early systemic sclerosis?. Advances in Rheumatology. 59(1). 19–19. 6 indexed citations
16.
Dutra, Lívia Almeida, et al.. (2019). Transcranial Doppler findings in antiphospholipid syndrome. Lupus. 28(4). 483–491. 6 indexed citations
17.
Sales, Lucas Peixoto, Marina Yázigi Solis, Ana Paula Hayashi, et al.. (2018). Omega-3 Fatty Acid Supplementation Improves Endothelial Function in Primary Antiphospholipid Syndrome: A Small-Scale Randomized Double-Blind Placebo-Controlled Trial. Frontiers in Immunology. 9. 336–336. 17 indexed citations
18.
Andrade, Danieli, et al.. (2018). Diagnosis and Management of Gastric Antral Vascular Ectasia. JCR Journal of Clinical Rheumatology. 26(2). 79–81. 4 indexed citations
19.
Quaresma, Maria Victória, et al.. (2017). Eosinophilic fasciitis during pregnancy: case report and review of literature. Rheumatology International. 38(3). 525–529. 4 indexed citations
20.
Andrade, Danieli, et al.. (2011). High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis. Rheumatology International. 32(6). 1549–1553. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary‐Carmen Amigo Breakdown of academic impact, for papers by Nathalie Morel Breakdown of academic impact, for papers by Alberto Spindler Breakdown of academic impact, for papers by Javier Cabiedes Breakdown of academic impact, for papers by R. H. W. M. Derksen Breakdown of academic impact, for papers by F Mujić Breakdown of academic impact, for papers by Sonja Praprotnik Breakdown of academic impact, for papers by Nicolas Limal Breakdown of academic impact, for papers by Chi Hung To Breakdown of academic impact, for papers by M. Ruivard
Rankless by CCL
2026